Avondale Partners Starts TrovaGene (TROV) at Market Perform
Tweet
Share
E-mailGet Alerts TROV Hot Sheet
Price: $1.19 --0%
Rating Summary:
7 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 27 | Down: 45 | New: 5
Rating Summary:
7 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 27 | Down: 45 | New: 5
Join SI Premium – FREE
Avondale Partners initiated coverage on TrovaGene (NASDAQ: TROV) with a Market Perform rating and a price target of $6.00.
For an analyst ratings summary and ratings history on TrovaGene click here. For more ratings news on TrovaGene click here.
Shares of TrovaGene closed at $5.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Sutro Biopharma (STRO) at Buy
- Deutsche Bank Starts Allwyn AG (ALWN:GA) at Hold
- Goldman Sachs Starts Anker Innovations Technology (668:HK) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Avondale PartnersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
